Reference: Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial by Sean Wharton, Paula Freitas, Jran Hjelmesth, Maria Kabisch, Kristian Kandler, Ildiko Lingvay, Maria Quiroga, Julio Rosenstock and W Timothy Garvey, 14 September 2025, The Lancet Diabetes & Endocrinology
Liu X, Eyles J, McLachlan AJ, Mobasheri A (2018) Which supplements can I recommend to my osteoarthritis patients
The spray format bypasses first-pass metabolism, offering researchers improved compound delivery for in vitro studies examining wound healing, angiogenesis, and tissue repair mechanisms
The protocol is registered with PROSPERO (CRD420250631751)
Alternatively, if approval is granted on a higher-than-necessary level of dosage, it is possible that tablets may be prescribed or subsequently used at a lower dose level (post-marketing dose reduction) to manage any undesirable effects
"We are pleased the court has rejected the compounders' attempts to undermine FDA's data-based decision that the shortage of Wegovy and Ozempic is resolved," said Steve Benz, Corporate Vice President, Legal and US General Counsel, Novo Nordisk